Dr. Nikhil Arvind Daga, MD

Dr. Daga practices at Huntington Ambulatory Surgery Center - HOPD in Pasadena, California.

Dr. Daga's NPI, 1487811212, was assigned on May 20, 2008. Dr. Daga graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2008. Dr. Daga's California license number on file is A110624.

Dr. Daga's primary practice is Huntington Ambulatory Surgery Center - HOPD, at 625 S Fair Oaks Ave, Pasadena, CA 91105.

Dr. Daga's primary practice is Huntington Ambulatory Surgery Center - HOPD in Pasadena, California. Dr. Daga is also affiliated with Huntington Hospital. The medical group on file is Foothill Cardiology Medical Group. Dmand AI also links Dr. Daga to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daga practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Daga's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Daga is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Daga has a license on file in California.

Dmand AI lists angioplasty, cardiac catheterization, circulation problems and endocarditis among the conditions Dr. Daga treats.

CMS data shows 1,780 Medicare services from Dr. Daga across 20 procedure codes in 2024, for 634 Medicare patients. Medicare paid $114,027 for them.

CMS counts 634 Medicare patients who saw Dr. Daga in 2024. The largest group is 75 to 84, with 283 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Daga's median patient age at 73, with 45% women.

In 2024, Dr. Daga wrote 4,873 Medicare Part D claims for 810 patients. 84% of them were for generic drugs. CMS names the drug for 4,656 of them, across 37 drugs with 11 or more claims each, at $842,932 in total drug cost. In 2023, CMS named 4,363 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Daga for performance year 2024, reported as part of a group. Dr. Daga accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Daga as offering telehealth. CMS counts 16 procedures of coronary angioplasty and stenting by Dr. Daga, more than 42% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Daga, published from 2013 to 2024. 2024 was the busiest year, with 2. Dr. Daga's most frequent co-authors are Khawaja A. Ammar, MD, Ezana M. Azene, MD, PhD and Brian Allan Bergmark, MD.

Dmand AI links Dr. Daga to 2 clinical trials. Conditions studied include Hemorrhagic Stroke, Pulmonary Embolism and Embolism.

CMS Open Payments shows 1,001 general payments to Dr. Daga from 60 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Edwards Lifesciences Corporation paid the most, $9,895.

Dr. Daga graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2008. Dr. Daga is a member of ACC.

Dr. Daga is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.